RE: Well here we go.....21 Feb 2022 10:47
For those who missed it earlier :)
This was said in Oct last year, a warning! Synairgen share price risks
Even though SNG001 is in Phase 3 trials, there is still a risk that it could prove ineffective in a larger trial group. If it does succeed in the trial, it could be a while before the product hits the market.
In the meantime, the company will have to try and keep the lights on. This is probably the most prominent risk investors face. If it takes longer than expected to get SNG001 to market, or if complications arise in the current set of trials, Synairgen could run out of money.
In this situation, it may have to ask shareholders for extra cash, which would dilute existing investors. There is no guarantee it would be able to raise the money, and in the worst-case scenario, Synairgen could collapse